[HTML][HTML] Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
A Castagnari - BMC proceedings - Springer
Abstract During the Experts Meeting on Lung Cancer, participants emphasized the
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
[PDF][PDF] Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
A Castagnari - BMC Proceedings, 2008 - Citeseer
Abstract During the Experts Meeting on Lung Cancer, participants emphasized the
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
A Castagnari - BMC Proceedings, 2008 - infona.pl
During the Experts Meeting on Lung Cancer, participants emphasized the usefulness of
erlotinib as second-line therapy for lung cancer. They noted that, although there are no …
erlotinib as second-line therapy for lung cancer. They noted that, although there are no …
[PDF][PDF] Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
A Castagnari - BMC Proceedings, 2008 - scienceopen.com
Abstract During the Experts Meeting on Lung Cancer, participants emphasized the
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
[HTML][HTML] Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
A Castagnari - BMC Proceedings, 2008 - bmcproc.biomedcentral.com
During the Experts Meeting on Lung Cancer, participants emphasized the usefulness of
erlotinib as second-line therapy for lung cancer. They noted that, although there are no …
erlotinib as second-line therapy for lung cancer. They noted that, although there are no …
Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option.
A Castagnari - BMC Proceedings, 2008 - europepmc.org
Abstract During the Experts Meeting on Lung Cancer, participants emphasized the
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
A Castagnari - BMC proceedings, 2008 - pubmed.ncbi.nlm.nih.gov
During the Experts Meeting on Lung Cancer, participants emphasized the usefulness of
erlotinib as second-line therapy for lung cancer. They noted that, although there are no …
erlotinib as second-line therapy for lung cancer. They noted that, although there are no …
[PDF][PDF] Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
A Castagnari - BMC Proceedings, 2008 - cyberleninka.org
Abstract During the Experts Meeting on Lung Cancer, participants emphasized the
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
[HTML][HTML] Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option
A Castagnari - BMC Proceedings, 2008 - ncbi.nlm.nih.gov
Abstract During the Experts Meeting on Lung Cancer, participants emphasized the
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
Conclusions of the expert panel: importance of erlotinib as a second-line therapeutic option.
A Castagnari - BMC Proceedings, 2008 - europepmc.org
Abstract During the Experts Meeting on Lung Cancer, participants emphasized the
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …
usefulness of erlotinib as second-line therapy for lung cancer. They noted that, although …